PowerUp Acquisition amends 8-K to correct redemption price to $284M ($10.55/share)

Aspire Biopharma Holdings, Inc.

Corrects redemption price from $283M ($10.51/share) to $284M ($10.55/share) for public shares tendered at May 2023 EGM.
26,946,271 public shares redeemed; approx $284M removed from trust account, leaving $19M and 1,803,729 shares outstanding.
No other changes to original filing; this is solely a price correction.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.